Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman, Dean Sheppard, Jeremy S. Duffield, et al.
Science Translational Medicine (2013) Vol. 5, Iss. 167
Closed Access | Times Cited: 623

Showing 1-25 of 623 citing articles:

Wound repair and regeneration: Mechanisms, signaling, and translation
Sabine A. Eming, Paul Martin, Marjana Tomic‐Canic
Science Translational Medicine (2014) Vol. 6, Iss. 265
Open Access | Times Cited: 2778
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Julia Beermann, Maria-Teresa Piccoli, Janika Viereck, et al.
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1297-1325
Closed Access | Times Cited: 1582
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke, Christine Hsu, Juliane S. Troeger, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 1230
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi, Scott L. Friedman, Yujin Hoshida
Advanced Drug Delivery Reviews (2017) Vol. 121, pp. 27-42
Open Access | Times Cited: 1204
Cellular and molecular mechanisms of repair in acute and chronic wound healing
Paul Martin, Robert Nunan
British Journal of Dermatology (2015) Vol. 173, Iss. 2, pp. 370-378
Open Access | Times Cited: 876
Hepatic Stellate Cells and Liver Fibrosis
Juan Enrique Puche, Yedidya Saiman, Scott L. Friedman
Comprehensive physiology (2013), pp. 1473-1492
Closed Access | Times Cited: 707
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Fei Liu, David Lagares, Kyoung Moo Choi, et al.
AJP Lung Cellular and Molecular Physiology (2014) Vol. 308, Iss. 4, pp. L344-L357
Open Access | Times Cited: 694
Fibroblasts: Origins, definitions, and functions in health and disease
Maksim V. Plikus, Xiaojie Wang, Sarthak Sinha, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3852-3872
Open Access | Times Cited: 681
TGF-β1 Signaling and Tissue Fibrosis
Kevin K. Kim, Dean Sheppard, Harold A. Chapman
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 4, pp. a022293-a022293
Open Access | Times Cited: 587
Evolving therapies for liver fibrosis
Detlef Schuppan, Yong Oock Kim
Journal of Clinical Investigation (2013) Vol. 123, Iss. 5, pp. 1887-1901
Open Access | Times Cited: 564
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi‐Sen Ding, Zhongwei Cao, Raphaël Lis, et al.
Nature (2013) Vol. 505, Iss. 7481, pp. 97-102
Open Access | Times Cited: 563
Cellular and molecular mechanisms in kidney fibrosis
Jeremy S. Duffield
Journal of Clinical Investigation (2014) Vol. 124, Iss. 6, pp. 2299-2306
Open Access | Times Cited: 555
Decoding myofibroblast origins in human kidney fibrosis
Christoph Kuppe, Mahmoud M. Ibrahim, Jennifer Kranz, et al.
Nature (2020) Vol. 589, Iss. 7841, pp. 281-286
Open Access | Times Cited: 539
The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
Boris Hinz
Matrix Biology (2015) Vol. 47, pp. 54-65
Open Access | Times Cited: 508
Extracellular matrix as a driver of progressive fibrosis
Jeremy Herrera, Craig A. Henke, Peter B. Bitterman
Journal of Clinical Investigation (2018) Vol. 128, Iss. 1, pp. 45-53
Open Access | Times Cited: 497
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan, Rambabu Surabattula, Xiaoyu Wang
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 238-250
Closed Access | Times Cited: 420
Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge
Bram Piersma, Ruud A. Bank, Miriam Boersema
Frontiers in Medicine (2015) Vol. 2
Open Access | Times Cited: 391
Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways
Ivan G. Gomez, Deidre A. MacKenna, Bryce G. Johnson, et al.
Journal of Clinical Investigation (2014) Vol. 125, Iss. 1, pp. 141-156
Open Access | Times Cited: 378
Mesenchymal Stem Cells in Fibrotic Disease
Elie El Agha, Rafael Kramann, Rebekka K. Schneider, et al.
Cell stem cell (2017) Vol. 21, Iss. 2, pp. 166-177
Open Access | Times Cited: 378
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan, Muhammad Ashfaq–Khan, Ai Ting Yang, et al.
Matrix Biology (2018) Vol. 68-69, pp. 435-451
Closed Access | Times Cited: 375
Myofibroblasts
Boris Hinz
Experimental Eye Research (2015) Vol. 142, pp. 56-70
Closed Access | Times Cited: 368
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Monika Lodyga, Boris Hinz
Seminars in Cell and Developmental Biology (2019) Vol. 101, pp. 123-139
Closed Access | Times Cited: 362
Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog
Maria Edeling, Grace Ragi, Shizheng Huang, et al.
Nature Reviews Nephrology (2016) Vol. 12, Iss. 7, pp. 426-439
Open Access | Times Cited: 359
TGF-β signaling in health and disease
Joan Massagué, Dean Sheppard
Cell (2023) Vol. 186, Iss. 19, pp. 4007-4037
Open Access | Times Cited: 334
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano, Luca Lavra, Alessandra Morgante, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 379-379
Open Access | Times Cited: 318
Page 1 - Next Page

Scroll to top